News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Anand Bhaskar
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/26/2023 |
4
| Anand Bhaskar (SVP, Chief Accounting Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 24,089 shares
@ $0
Disposed/sold 15,000 options to buy
@ $137.47, valued at
$2.1M
Disposed/sold 23,438 options to buy
@ $27.32, valued at
$640.3k
Disposed/sold 6,000 options to buy
@ $28.78, valued at
$172.7k
Disposed/sold 33,500 options to buy
@ $36.71, valued at
$1.2M
|
|
| 08/17/2023 |
4
| Anand Bhaskar (SVP, Chief Accounting Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Sold 193 shares
@ $169.055, valued at
$32.6k
Sold 210 shares
@ $168.4184, valued at
$35.4k
|
|
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
4
| Anand Bhaskar (SVP, Chief Accounting Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Sold 2,343 shares
@ $102.1118, valued at
$239.2k
Exercised 1,562 options to buy
@ $27.32, valued at
$42.7k
|
|
| 05/17/2023 |
4
| Anand Bhaskar (SVP, Chief Accounting Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Sold 950 shares
@ $85.9833, valued at
$81.7k
Sold 136 shares
@ $81.1038, valued at
$11k
|
|
| 05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/08/2023 |
4
| Anand Bhaskar (SVP, Chief Accounting Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Sold 165 shares
@ $84.58, valued at
$14k
|
|
| 03/06/2023 |
4
| Anand Bhaskar (SVP, Chief Accounting Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Sold 820 shares
@ $87.47, valued at
$71.7k
|
|
| 03/02/2023 |
4
| Anand Bhaskar (SVP, Chief Accounting Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 3,000 shares
@ $0
Granted 6,000 options to buy
@ $28.78, valued at
$172.7k
|
|
| 01/04/2023 |
4
| Anand Bhaskar (VP, Chief Accounting Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 8,250 shares
@ $0
Granted 33,500 options to buy
@ $36.71, valued at
$1.2M
|
|
| 01/05/2022 |
4
| Anand Bhaskar (VP, Chief Accounting Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 12,500 shares
@ $0
Granted 25,000 options to buy
@ $27.32, valued at
$683k
|
|
| 11/15/2021 |
3
| Anand Bhaskar (VP, Chief Accounting Officer) has filed a Form 3 on REATA PHARMACEUTICALS INC |
|
|